Skip to main content
Professional Technical IVT

MOG

Also written as: MOG — myelin oligodendrocyte glycoprotein

Myelin oligodendrocyte glycoprotein, a surface protein of myelin sheaths targeted in certain autoimmune CNS diseases.

Full Definition

Myelin oligodendrocyte glycoprotein (MOG) is a glycoprotein found on the outermost surface of myelin sheaths in the central nervous system. It constitutes only a small percentage of total myelin protein but serves as an important target for autoimmune attack in certain neuroinflammatory conditions. MOG-associated disease (MOGAD) has emerged as a distinct clinical entity separate from multiple sclerosis and neuromyelitis optica, characterized by specific antibody responses against MOG. These antibodies can be detected through cell-based assays and are associated with particular clinical phenotypes including optic neuritis, acute disseminated encephalomyelitis, and brainstem encephalitis. MOG antibody-positive patients often show different treatment responses compared to other demyelinating diseases.

Usage

Usage note: When referring to antibodies, specify 'MOG antibodies' rather than just 'MOG-positive'.

In Context

  • "Serum testing revealed positive MOG antibodies, supporting a diagnosis of MOG-associated disease." — Laboratory report
  • "The patient's clinical presentation was consistent with MOG antibody-positive optic neuritis." — Clinical assessment

Also known as

myelin oligodendrocyte glycoprotein

Don't confuse with

MBP PLP aquaporin-4

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON